维普中文期刊产品整合服务
17篇 您的检索式:作者名="Traynor AM"
    题名 作者 年代 出处 被引量
1Dosing to rash: A phase Ⅱ trial of the first - line erlotinib for patients with advanced non - small - cell lung can- cer an Eastern Cooperative Oncology Group Study显示文摘Brahmer JR Lee JW Traynor AM 2013Eur J Cancer2013,15,:1
2Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer显示文摘Traynor AM Weigel TL Oettel KR 2013Lung Cancer2013,81,1:1
3Non - small - cell lung canc-er and breast carcinoma: chemotherapy and beyond 显示文摘Dubey S JM Siegfried AM Traynor 2006Lancet0ncol2006,7,5:1
4Pilot study of gefitinib and fnlvestrant in the treatment of post- menopausal women with advanced non-small cell lung cancer 显示文摘Traynor AM Schiller JH Stabile LP 2009Lung Cancer2009,64,1:1
5A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer 显示文摘Doebele RC Conkling P Traynor AM 2012Annals of Oncology2012,23,8:1
6Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer 显示文摘Traynor AM Schiller JH Stabile LP 2009Lung Cancer2009,64,1:1
7Nuclear EGFR protein expression predicts poor survival in early stage non- small cell lung cancer 显示文摘Traynor AM Weigel TL Oettel KR 2013Lung Cancer2013,81,1:1
8Vorinostat (NSC#701852) in patients with relapsed non-small cell lung cancer:a Wisconsin Oncology Network phase II study显示文摘Traynor AM Dubey S Eickhoff JC 2009J Thorac Oncol2009,4,4:1
9Nuclear EGFR protein expression predicts poor survival in early stage non - small cell lung cancer显示文摘Traynor AM Weigel TL Oettel KR 2013Lung Cancer (Amsterdam Netherlands)2013,81,1:1
10A phase I, open-label dose-escalation study of continuous treatment with BIBF 1120 in combination with paclitaxel and carboplatin as first-line treatment in patients with advanced non-small-cell lung cancer显示文摘Doebele RC Conkling P Traynor AM 2012Ann Oncol2012,23,8:1
11A phase Ⅱ trim of tria- pine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative On- tology Group Study 1503显示文摘Traynor AM Lee J-W Bayer GK 2010Invest New Drugs2010,28,1:1
12Systemic treatment of advanced non-small cell lung cancer显示文摘Traynor AM Schiller JH 2004Drugs Today(Barc)2004,40,8:1
13Vorinostat (NSC#701852) in patients with relapsed non-small cell lung cancer:a Wisconsin Oncology Network phase Ⅱ study显示文摘Traynor AM Dubey S Eickhoff JC 0,,04:1
14显示文摘 Traynor AM Pope R 1998Blood1998,92,:1
15A phase II trial of Triapine (NSC # 663249 ) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503 显示文摘TRAYNOR AM LEE JW BAYER GK 2010Invest New Drugs2010,28,1:1
16Pilot study of ge- fitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer 显示文摘Traynor AM Schiller JH Stabile LP 2009Lung Cancer2009,64,1:1
17Pilot study of gefitinib and fulvestrant in the treatment of post- menopausal women with advanced non-small cell lung cancer 显示文摘Traynor AM Schiller JH Stabile LP 2009Lung Cancer2009,64,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费